Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1665086

registered interest
date	16/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rare Diseases: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many single technology appraisals for medicines for rare diseases conducted by the National Institute for Health and Care Excellence resulted in (a) a positive recommendation, (b) an optimised recommendation, (c) a recommendation for managed access, (d) a negative recommendation and (e) termination in each financial year since 2018-19.
tabling member constituency	Bolton West
tabling member printed	Chris Green
uin	202779
answer	answer is ministerial correction date of answer 20/10/2023 answer text <p>The following table shows a breakdown of technologies with designated orphan status appraised through the National Institute for Health and Care Excellence resulted single technology appraisal process by financial year from 2018/19:</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>2018/19</p></td><td><p>2019/20</p></td><td><p>2020/21</p></td><td><p>2021/22</p></td><td><p>2022/23</p></td><td><p>Total</p></td></tr><tr><td><p>Recommended</p></td><td><p>2</p></td><td><p>1</p></td><td><p>6</p></td><td><p>11</p></td><td><p>5</p></td><td><p>25</p></td></tr><tr><td><p>Recommended (Cancer Drugs Fund)</p></td><td><p>2</p></td><td><p>2</p></td><td><p>4</p></td><td><p>0</p></td><td><p>0</p></td><td><p>8</p></td></tr><tr><td><p>Optimised</p></td><td><p>3</p></td><td><p>9</p></td><td><p>3</p></td><td><p>3</p></td><td><p>8</p></td><td><p>26</p></td></tr><tr><td><p>Optimised (Cancer Drugs Fund)</p></td><td><p>1</p></td><td><p>1</p></td><td><p>0</p></td><td><p>1</p></td><td><p>0</p></td><td><p>3</p></td></tr><tr><td><p>Research Only</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td><td><p>0</p></td></tr><tr><td><p>Not Recommended</p></td><td><p>2</p></td><td><p>0</p></td><td><p>0</p></td><td><p>1</p></td><td><p>2</p></td><td><p>5</p></td></tr><tr><td><p>Total</p></td><td><p>10</p></td><td><p>13</p></td><td><p>13</p></td><td><p>16</p></td><td><p>15</p></td><td><p>67</p></td></tr><tr><td><p>Terminated</p></td><td><p>1</p></td><td><p>5</p></td><td><p>5</p></td><td><p>10</p></td><td><p>2</p></td><td><p>23</p></td></tr></tbody></table><p> </p><p>Medicines with an orphan designation are for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition that is rare, namely affecting not more than five in 10,000 people in Great Britain, or where the medicine is unlikely to generate sufficient profit to justify research and development costs.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/10/2023 11:24:13 answering member 4423 label Biography information for Will Quince
tabling member	4398 label Biography information for Chris Green

64341

registered interest
date	26/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Knee Replacements
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the cost was of NHS knee replacement operations and subsequent revisions in England in the last three years.
tabling member constituency	Harlow
tabling member printed	Robert Halfon
uin	202779
answer	answer is ministerial correction date of answer 03/07/2014 answer text <p>The information requested is not held centrally.</p><p> </p><p>Such information as is available is from reference costs, which are the average cost to National Health Service trusts and NHS foundation trusts of providing defined services in a given financial year to NHS patients. Reference costs for acute care are collected by Healthcare Resource Groups (HRGs), which are standard groupings of clinically similar treatments that consume common levels of healthcare resource. The HRGs in the attached table therefore include the costs of other knee procedures in addition to knee replacements.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 03/07/2014 15:38:13 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ202779 - Table.docx title Table
tabling member	3985 label Biography information for Robert Halfon